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Introduction
Dehydroepiandrosterone (DHEA) and its sulphate (DHEAS)
are the most abundant steroids secreted by the adrenal
cortex [1]. The concentration of DHEA in the blood oscillates
in parallel with cortisol, in response to levels of adrenocortico-
trophic hormone (ACTH), but without feedback control at the
hypothalamic–pituitary level.
ACTH = adrenocorticotrophic hormone; APACHE = Acute Physiology and Chronic Health Evaluation; DHEA(S) = dehydroepiandrosterone (sul-
phate); HPA = hypothalamic–pituitary–adrenal; IL = interleukin; TNF = tumour necrosis factor.
Abstract
Introduction  Dehydroepiandrosterone (DHEA) and its sulphate (DHEAS) are pleiotropic adrenal
hormones with immunostimulating and antiglucocorticoid effects. The present study was conducted to
evaluate the time course of DHEAS levels in critically ill patients and to study their association with the
hypothalamic–pituitary–adrenal axis.
Materials and method This was a prospective observational clinical and laboratory study, including
30 patients with septic shock, eight patients with multiple trauma, and 40 age- and sex-matched
control patients. We took serial measurements of blood concentrations of DHEAS, cortisol, tumour
necrosis factor-α and IL-6, and of adrenocorticotrophic hormone immunoreactivity over 14 days or until
discharge/death.
Results On admission, DHEAS was extremely low in septic shock (1.2 ± 0.8 µmol/l) in comparison
with multiple trauma patients (2.4 ± 0.5 µmol/l; P < 0.05) and control patients (4.2 ± 1.8; P < 0.01).
DHEAS had a significant (P < 0.01) negative correlation with age, IL-6 and Acute Physiology and
Chronic Health Evaluation II scores in both patient groups. Only during the acute phase did DHEAS
negatively correlate with dopamine. Nonsurvivors of septic shock (n = 11) had lower DHEAS levels
(0.4 ± 0.3 µmol/l) than did survivors (1.7 ± 1.1 µmol/l; P < 0.01). The time course of DHEAS exhibited
a persistent depletion during follow up, whereas cortisol levels were increased at all time points.
Conclusion We identified extremely low DHEAS levels in septic shock and, to a lesser degree, in
multiple trauma patients as compared with those of age- and sex-matched control patients. There
appeared to be a dissociation between DHEAS (decreased) and cortisol (increased) levels, which
changed only slightly over time. Nonsurvivors of sepsis and patients with relative adrenal insufficiency
had the lowest DHEAS values, suggesting that DHEAS might be a prognostic marker and a sign of
exhausted adrenal reserve in critical illness.
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The physiological role and biological actions of DHEA(S) are
not well known but studies in humans suggest a positive impact
on sense of well-being [2], and DHEA has recently been recog-
nized as a potent modulator of the immune response [1]. DHEA
improved host defences by restoring immune cell function and
reversed susceptibility to infection [3].
Serum DHEA(S) concentration was low in patients with
primary adrenal insufficiency, and short-term oral DHEA
replacement improved the clinical condition of these
patients [2,4]. Functional or relative adrenal insufficiency
frequently occurs in critically ill patients, with possible fatal
consequences, although diagnostic criteria for this entity
still pose problems [5]. We hypothesize that the serum
DHEAS level has utility as a diagnostic tool and a prognos-
tic marker in such patients. Furthermore, low serum concen-
trations of DHEAS might be a more sensitive marker of
hypothalamic–pituitary–adrenal (HPA) hypofunction than is
glucocorticoid secretion.
The present study was conducted to evaluate the time course
of DHEAS levels (an immunostimulator) as compared with
those of cortisol (an immunosuppressor), ACTH (an inducer
of DHEAS) and cytokines (stimulators of the HPA axis) in
patients with critical illness and in age- and sex-matched
control patients.
Materials and method
Study design
This was a prospective, observational, clinical and laboratory
study conducted in a 20-bed medical/surgical/neurosurgical
intensive care unit.
Patients
Approval for the study was obtained from our institutional
Human Subjects Research Committee, and written informed
consent from first-degree relatives was mandatory. Thirty-
eight consecutive patients who were admitted to the inten-
sive care unit with septic shock (n = 30) or severe multiple
trauma (Injury Severity Score >20; n = 8) were included in
the study within 6 hours after admission. Exclusion criteria
were as follows: age under 18 years; use of corticosteroids,
DHEA or other drugs that affect the HPA axis; pre-existing
adrenal insufficiency or known abnormalities of the HPA axis;
and presence of diabetes mellitus or congestive heart failure.
Age- and sex-matched control patients (n = 40) were patients
without acute medical illness who were admitted to the
medical department for routine diagnosis and treatment.
Data collection
In patients with septic shock or multiple trauma, Acute Physi-
ology and Chronic Health Evaluation (APACHE) II and
Sequential Organ Failure Assessment scores, and intensive
care unit mortality were used to assess the severity of
disease. In addition, use of dopamine (cumulative dose in mil-
ligrams per day) was recorded.
We obtained serial blood samples for measurement of serum
cortisol and DHEAS, and plasma ACTH, IL-6 and tumour
necrosis factor (TNF)-α once a day between 0700 and
0800 h. Follow up was conducted for 14 days, or until death
or discharge from the intensive care unit. Blood samples
were stored at –70°C until use.
Immunoreactive DHEAS, cortisol, ACTH, TNF-α and IL-6
concentrations were measured using commercially available
chemiluminescent enzyme immunoassays with the Immulite
Automated Immunoassay System (Diagnostic Products Corp,
Los Angeles, CA, USA).
In patients with clinical suspicion of (relative) adrenal insuffi-
ciency (unexplained hypotension and resistance to inappro-
priately high doses of vasoactive drugs) a low-dose ACTH
(1 µg) stimulation test was performed. A normal cortisol
response was defined as greater than 550 nmol/l after stimu-
lation and an increase of 150 nmol/l or more [6].
Statistical analysis
Values are expressed as means ± SD. Qualitative data were
analysed using the χ2 test. Groups were compared using the
Kruskal–Wallis test, with Dunn’s test for multiple compar-
isons. The Spearman rank order correlation coefficient (rs)
was used to evaluate relations for individual data. P < 0.05
was considered statistically significant. All analyses were per-
formed using a statistical software package (SPSS 9.0.1;
SPSS Inc, Chicago, IL, USA).
Results
The clinical and laboratory characteristics of the patients and
control groups on admission are summarized in Table 1. On
admission, patients with septic shock had significantly lower
DHEAS levels (1.2 ± 0.8 µmol/l) than did those with multiple
trauma (2.4 ± 0.5 µmol/l,  P < 0.05) and control patients
(4.2 ± 1.8 µmol/l, P < 0.01). There was a significant negative
correlation between DHEAS and age (rs = –0.55, P < 0.01)
in the patient groups (pooled), but there was no significant
difference in DHEAS concentrations between male and
female patients. We found a negative correlation between
DHEAS and dopamine only during the acute phase (septic
shock:  rs = –0.60; trauma: rs = –0.55;  P < 0.01). Also, the
correlation between DHEAS and IL-6 (septic shock:
rs = –0.61, P < 0.01; trauma: rs = 0.47, P < 0.05) was more
pronounced during the acute phase. These correlations were
lost during prolonged illness (after 5 days).
The time course of DHEAS during the observation period of
14 days is shown in Fig. 1. In both septic and trauma
patients, DHEAS concentrations were consistently lower than
those in control patients over time. In contrast, cortisol levels
were persistently elevated at all time points, in both septic
and trauma patients. On admission, nonsurvivors of septic
shock (n = 11) had lower DHEAS levels (0.4 ± 0.3 µmol/l)
than did survivors (1.7 ± 1.1 µmol/l,  P < 0.01). In addition,Critical Care    October 2002 Vol 6 No 5 Beishuizen et al.
DHEAS was inversely correlated with APACHE II (rs = –0.52,
P < 0.01) and Sequential Organ Failure Assessment
(rs = –0.45, P < 0.05) scores.
In eight septic patients there was clinical suspicion of (rela-
tive) adrenal insufficiency, which was confirmed by a blunted
response to low-dose ACTH in four cases. The patients with
adrenal insufficiency had lower DHEAS levels at the time of
testing (0.35 ± 0.3 µmol/l) than did those with ‘normal’
adrenal function (1.3 ± 0.8 µmol/l, P < 0.05).
Discussion
We found a clear dissociation between high blood levels of
cortisol and extremely low levels of DHEAS in critically ill
patients in both the acute and prolonged phases. Parker and
coworkers [7] demonstrated such a divergence in adrenal
steroid secretion; in that study serum cortisol was increased
in adult men with burn injuries, whereas serum DHEAS was
reduced. Luppa and coworkers [8] studied serum androgens
in a large group of critically ill patients and also found
markedly decreased DHEAS levels in both males and
females, mainly in those patients with a prolonged clinical
course. These data indicate a shift in adrenal steroid synthe-
sis away from mineralocorticoids and androgens and toward
excessive cortisol production. The dissociation between
blood levels of cortisol and DHEAS appears to be a contra-
diction because both hormones are synthesized and secreted
mainly by the adrenal cortex. However, DHEAS is produced
mainly in the zona reticularis of the adrenal cortex, possibly
indicating that a differential alteration in the cortical zone is
responsible for DHEAS deficiency during severe critical
illness.
The sustained hypercortisolism, as opposed to the marked
DHEAS depletion, during severe critical illness could theoreti-
cally result in an imbalance between immunosuppressive and
immunostimulatory pathways, and may therefore play a role in
susceptibility to infectious complications [1].
Interestingly, we found the lowest DHEAS and the highest
cortisol levels in nonsurvivors and the most severely ill
patients, indicating that the DHEAS : cortisol ratio might be a
prognostic indicator for outcome of critical illness, in particu-
lar septic shock. Interpretation of cortisol levels measured in
seriously ill patients is difficult. Serum cortisol levels that are
regarded as high in control individuals may be inappropriately
Table 1
Clinical and laboratory data on admission in patients with septic shock or multiple trauma, and age- and sex-matched control
patients
Parameter Septic shock Multiple trauma Control patients
n 30 8 40
Mean age (years) 62 ± 11 52 ± 15 56 ± 14
Sex (male/female) 20/10 7/1 28/12
APACHE II score 16.2 ± 5.3**†† 10.1 ± 2.9** 3.2 ± 2.7
SOFA score 8.2 ± 3.2**†† 4.2 ± 2.2** 1.9 ± 1.5
Survival (n)1 9 8 4 0
DHEAS (µmol/l) 1.2 ± 0.8**† 2.4 ± 0.5* 4.2 ± 1.8
Cortisol (µmol/l) 1.09 ± 0.23** 1.03 ± 0.19** 0.32 ± 0.08
ACTH (pmol/l) 115.1 ± 29.2** 109.4 ± 36.2** 11.2 ± 4.5
IL-6 (pmol/l) 1301 ± 377**†† 555 ± 256** 10.2 ± 4.8
TNF-α (pmol/l) 26.3 ± 9.6**†† 9.4 ± 2.1* 4.2 ± 2.2
Values are means ± SD. ACTH, adrenocorticotrophic hormone; APACHE, Acute Physiology and Chronic Health Evaluation; DHEAS,
dehydroepiandrosterone sulphate; SOFA, Sequential Organ Failure Assessment; TNF, tumour necrosis factor. *P < 0.05 versus control; **P < 0.01
versus control; †P < 0.05 versus multiple trauma; ††P < 0.01versus multiple trauma.
Figure 1
The time course of serum dehydroepiandrosterone sulphate (DHEAS)
levels in patients with septic shock (), patients with multiple trauma
(), and age- and sex-matched control patients ().low in patients who are severely ill. We recently showed that
functional or relative adrenal insufficiency can be present in
critically ill patients despite ‘high’ initial serum cortisol levels
[5]. By using the low-dose ACTH stimulation test and Thorn
test, we demonstrated the relative lack of adrenocortical
response to extra stimulation by ACTH in some critically ill
patients, because their HPA axis is already maximally stimu-
lated. In the present study the low-dose ACTH test identified
four patients out of eight with a clinical suspicion for relative
adrenal insufficiency. These patients had very low serum con-
centrations of DHEAS, which may also be a sign of limited
adrenocortical reserve arising during the course of critical
illness [6].
In both septic and trauma patients we found a similar degree
of stimulation of the HPA axis; however, patients with septic
shock were more severely ill than were patients with multiple
trauma, as reflected by their APACHE II scores, and TNF-α
and IL-6 levels. One could argue that this also indicates a
state of exhausted adrenal reserve.
We found a relation between dopamine use and DHEAS
levels, but only during the acute phase. Therefore, acute
depletion of DHEAS might reflect the liberal use of dopamine
[9]. In addition, we found a negative correlation between IL-6
and DHEAS during the acute phase. In healthy persons,
serum IL-6 correlated inversely with DHEAS, and DHEA
administration led to inhibition of IL-6 secretion from mono-
cytes, indicating a functional link between DHEAS and IL-6
[10]. IL-6 can act synergistically with ACTH on the adrenal
glands to release cortisol [11]. Therefore, IL-6 may be an
important regulator of DHEAS in (acute) critical illness.
However, the dopamine dosage and IL-6 levels decreased
significantly over time whereas DHEAS concentrations
remained low, suggesting different mechanisms for the pro-
longed DHEAS depletion during critical illness.
We found a negative correlation between age and DHEAS
concentrations. DHEAS concentrations exhibit a biphasic
time course following the onset of adrenarche, reaching a
peak between the ages 20 and 30 years, and with the great-
est decline occurring by age 50–60 years [12,13]. This dra-
matic age-related reduction might be caused by a specific
defect in the desmolase activity in the reticular zone of the
adrenal gland. Most of patients studied here, including
control patients, were aged approximately 50–60 years.
In conclusion, we found extremely low DHEAS levels in virtu-
ally all critically ill patients, in both septic shock and multiple
trauma. DHEAS depletion was associated with a worse
outcome and represents a prognostic marker. Acute deple-
tion of DHEAS is probably related to the use of dopamine
and high IL-6 levels. The prolonged depletion of DHEAS
might reflect an exhausted adrenal adaptation. Whether
DHEA should be administered in DHEAS-deficient states
remains to be elucidated. However, theoretically, beneficial
effects on immunity, susceptibility for infections and well-
being may be expected.
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Key messages
• Critically ill patients exhibit a remarkable depletion in
DHEAS in both acute and chronic phases, suggesting
an exhausted adrenal adaptation
• There is a clear dissociation between DHEAS
(decreased) and cortisol (increased) levels in critically
ill patients, indicating a disturbed balance between
immunostimulatory and immunosuppressive factors
• DHEAS appears to be a prognostic marker, because
nonsurvivors of septic shock have extremely low
DHEAS levels
• The acute depletion of DHEAS is probably related to
the use of dopamine and the high IL-6 levels during the
acute phase of critical illness
• The prolonged depletion of DHEAS during critical
illness is unexplained, but supports the hypothesis of
an exhausted neuroendocrine system, and necessi-
tates an interventional study with substitution doses of
DHEA, considering the expected beneficial effects on
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